Order Article Reprints

Pritchard KI, Gelmon KA, Rayson D, Provencher L, Webster M, McLeod D, Verma S. Endocrine Therapy for Postmenopausal Women with Hormone Receptor–Positive her2–Negative Advanced Breast Cancer after Progression or Recurrence on Nonsteroidal Aromatase Inhibitor Therapy: A Canadian Consensus Statement. Current Oncology. 2013; 20(1):48-61. https://doi.org/10.3747/co.20.1316

Pritchard, K.I., K.A. Gelmon, D. Rayson, L. Provencher, M. Webster, D. McLeod, and S. Verma. 2013. "Endocrine Therapy for Postmenopausal Women with Hormone Receptor–Positive her2–Negative Advanced Breast Cancer after Progression or Recurrence on Nonsteroidal Aromatase Inhibitor Therapy: A Canadian Consensus Statement" Current Oncology 20, no. 1: 48-61. https://doi.org/10.3747/co.20.1316

Pritchard, K. I., Gelmon, K. A., Rayson, D., Provencher, L., Webster, M., McLeod, D., & Verma, S. (2013). Endocrine Therapy for Postmenopausal Women with Hormone Receptor–Positive her2–Negative Advanced Breast Cancer after Progression or Recurrence on Nonsteroidal Aromatase Inhibitor Therapy: A Canadian Consensus Statement. Current Oncology, 20(1), 48-61. https://doi.org/10.3747/co.20.1316